Compare Aptos (APT) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aptos vs Injective — how do they compare? Aptos trades at Rp9,816 (market cap Rp8,47T, Rp426,89M 24h volume), while Injective trades at Rp81,527 (market cap Rp8,14T, Rp770,73M 24h volume). The key difference: Aptos and Injective are close in size by market cap, and Aptos's supply is capped (857,4M / 2,1B APT (41%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 33 Days and Injective for 37 Days on average.
| APT | INJ | |
|---|---|---|
Market Cap | Rp8,47T | Rp8,14T |
Volume (24h) | Rp426,89M | Rp770,73M |
Circulating Supply | 857,4M / 2,1B APT (41%) | 100M INJ |
Typical Hold Time | 33 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aptos is trading at Rp9,846, showing a bearish technical outlook with moving averages signaling strong selling pressure, though oscillators are neutral. The current price sits below the pivot point of Rp10,023, with immediate support at Rp9,908. On-chain metrics indicate a circulation rate of 41% and an average hold time of 33 days, suggesting moderate network participation. Recent news highlights the project's operational stability, but specific crypto ecosystem updates are limited.
Overall, the outlook is cautious due to bearish technicals and neutral fundamentals. Key opportunities lie in potential rebounds from oversold RSI levels, while major risks include sustained selling pressure and lack of recent protocol developments. Investors should monitor support levels and broader market sentiment.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aptos
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
